Find uplifting stories about heroes, innovations, and solutions
8246 results for "skin cancer treatment"
Scientists have discovered how to boost immune cells by changing their metabolism, opening a promising new path to treat skin cancers that resist current therapies. Clinical trials are already testing these metabolic treatments alongside immunotherapy.
A Moderna immunotherapy for melanoma continues to protect patients years after treatment, new data shows. The results bring hope for a cancer vaccine that could change how we fight one of the deadliest skin cancers.
A breakthrough therapy is giving advanced melanoma patients new hope by supercharging their own immune systems to fight cancer. One survivor has remained cancer-free for six years after treatment.
Blood cancer patients in Kansas can now access a one-time therapy that could replace lifelong chemotherapy cycles. The breakthrough CAR T-cell treatment genetically modifies patients' own immune cells to fight cancer.
A Florida hospital is enrolling patients in a groundbreaking international study that could dramatically improve survival rates for advanced skin cancer. The trial tests whether immunotherapy before surgery can stop one of America's most common cancers from coming back.
Doctors are catching ovarian cancer earlier and keeping it away longer with personalized treatments and genetic testing. These advances are giving patients real hope where there was once only uncertainty.
Scientists discovered two proteins that control how skin cells grow and heal, opening doors to better treatments for wounds, inflammation, and skin cancer. The breakthrough could transform how doctors treat everything from psoriasis to aging skin.
Scientists discovered how to beat triple-negative breast cancer at its own game by blocking an enzyme that helps tumors survive treatment. The approach not only damages cancer cells directly but also calls in the immune system for backup.
A groundbreaking study will use advanced imaging to personalize cancer treatment, potentially cutting unnecessary therapy while helping more patients access care. The collaboration could transform how doctors decide when prostate cancer patients have received enough treatment.
A groundbreaking combination therapy is giving women with HER2-positive metastatic breast cancer significantly more time, setting a new standard for first-line treatment. The DESTINY-Breast09 trial shows the treatment works across different patient groups, offering hope to thousands.
Researchers at Monash University discovered that delivering cancer immunotherapy under the skin with an enzyme booster makes treatment work better while being more comfortable for patients. This breakthrough could transform how millions receive life-saving cancer care.
Women with triple-negative breast cancer just gained two powerful new treatment options that work better than standard chemotherapy at keeping the disease under control. The FDA approved Trodelvy alone and combined with immunotherapy as first-line treatments for this aggressive cancer type.
A groundbreaking cancer treatment just gave patients with hard-to-treat lung cancer something they desperately needed: hope. Chinese biotech company Akeso's new drug ivonescimab beat the current standard treatment in a major clinical trial, marking a historic win for patients with limited options.
A small Canadian city is funding a massive expansion that will bring lifesaving chemotherapy care closer to home for cancer patients who currently face exhausting travel for treatment. Breast cancer survivor Teri Peters knows firsthand why six new treatment chairs will change everything.
A short burst of immunotherapy before surgery has kept every patient in a UK colorectal cancer trial cancer-free for nearly three years. The breakthrough challenges decades of standard treatment and offers hope for thousands.
Scientists at Oregon Health & Science University discovered that stress nerves help pancreatic tumors grow, opening doors to potential new treatments. The breakthrough could transform how we fight one of the deadliest cancers.
Cancer patients gained several new FDA-approved tools this week, including tests to guide treatment decisions and drug combinations for hard-to-treat cancers. These advances offer fresh hope for more personalized, effective care.
The FDA just approved Optune Pax, a new treatment option for people battling locally advanced pancreatic cancer. This approval brings fresh hope to patients facing one of the most challenging cancer diagnoses.
A new radiation treatment for advanced prostate cancer is helping patients skip harsh chemotherapy while getting better results. Texas Oncology in Longview is now offering Pluvicto, which delivers radiation directly to cancer cells.
A breakthrough treatment for pancreatic cancer shows promise in doubling how long patients survive with one of the deadliest forms of cancer. This medical advance offers new hope for thousands of families facing this devastating diagnosis.
Showing 20 of 8246